The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics

Overview of attention for article published in European Journal of Heart Failure, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Dimensions has found 170 publications that cite this research output.

Article in JACC Heart Failure (March 2024)

Article in International Journal of Drug Discovery and Pharmacology (March 2024)

Article in Diabetes/Metabolism Research and Reviews (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.